Infectious Disease Alert – March 1, 2015
March 1, 2015
View Issues
-
Measles in Our Not-So-Magical Kingdom
ABSTRACT & COMMENTARY: Routine vaccination would have prevented most of these recent cases in California.
-
Combination Therapy for Invasive Aspergillosis in Patients with Hematologic Malignancies or Hematopoeitic Cell Transplants
In an evaluation of the primary endpoint, all-cause mortality at 6 weeks, there was no statistically significant difference between treatment with voriconazole alone or in combination with anidulafungin in patients with invasive aspergillosis and hematologic malignancies or hematopoietic stem cell transplants.
-
Deworming Is Beneficial in HIV-infected Patients
988 HIV-infected pregnant women receiving ART in sub-Saharan Africa were treated with albendazole in a targeted or non-targeted fashion. Albendazole therapy was associated with favorable changes in hemoglobin levels, CD4 counts, and viral loads, particularly in patients with helminth infections.
-
Ceftolozane/Tazobactam — Formulary Considerations
Information about ceftolozane/tazobactam
-
Antibiotics for Traveler’s Diarrhea?
Foreign travel is associated with travelers’ diarrhea and the intestinal acquisition of extended-spectrum beta lactamase-producing Enterobacteriaceae, especially when travel is to South Asia. The risk of acquisition of resistant flora was almost doubled when antibiotics were used to treat the episode of diarrhea.
-
Infectious Disease Alert Updates
The problem of diagnosing TB in children
How best to treat latent TB?
Transmission risk in smear-negative TB